Photodynamic therapy with topical 5-aminolevulinic acid for the treatment of skin cancers

Photodynamic therapy with topical 5-aminolevulinic acid for the treatment of skin cancers - Photodynamic therapy with topical 5-aminolevulinic acid for the treatment of skin cancers

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004329

Enrollment

Registered

2010-10-06

Start date

2010-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

skin cancers

Interventions

20% 5-aminolevulinic acid in emulsifying ointment will be applied to the surface of skin cancer. The treatment area will be covered with an adhesive dressing plus a light opaque dressing for 4 hours.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who gave their written informed consent

Exclusion criteria

Exclusion criteria: Patients who are considered unsuitable for this study by the investigator

Design outcomes

Primary

Measure	Time frame
Efficacy of therapy with 5-aminolevulinic acid in patients with skin cancers	—

Countries

Japan

Contacts

Public ContactToshiyuki Ozawa

Osaka City University Department of Plastic and Reconstructive Surgery

ozawa@med.osaka-cu.ac.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026